Contact Us
  Search
The Business Research Company Logo

OTC Dry Eye Drops Market Report 2026

Buy Now
Global OTC Dry Eye Drops Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

OTC Dry Eye Drops Market Report 2026

Global Outlook – By Brand Classification (Generics, Branded), By Product (Preservatives Free, With Preservatives), By Viscosity (High Viscosity, Low Viscosity), By Distribution Channel (Online Pharmacies, Drugstores And Supermarkets, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

OTC Dry Eye Drops Market Overview

• OTC Dry Eye Drops market size has reached to $3.77 billion in 2025 • Expected to grow to $5.33 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Increasing Screen Exposure Fueling Market Growth Due to Rising Digital Eye Strain and Visual Fatigue • Market Trend: Shift Toward Preservative-Free Technologies Enhances Safety and Long-Term Tolerability in OTC Dry Eye Drops • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under OTC Dry Eye Drops Market?

OTC (Over-the-counter) dry eye drops refer to non-prescription eye drops that are available for purchase directly from pharmacies, drugstores, and online retailers without a doctor's prescription. They are used to provide temporary relief from the symptoms of dry eyes and improve overall eye comfort. The main types of OTC dry eye drops are generic and branded. Generics refer to dry eye drops that contain the same active ingredients as branded products but are sold under their chemical names. The various products include preservatives free and with preservatives, which are available with high viscosity and low viscosity. These are sold through various distribution channels, such as online pharmacies, drugstores and supermarkets, retail pharmacies, and other distribution channels.
OTC Dry Eye Drops Market Global Report 2026 Market Report bar graph

What Is The OTC Dry Eye Drops Market Size and Share 2026?

The otc dry eye drops market size has grown strongly in recent years. It will grow from $3.77 billion in 2025 to $4.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of dry eye syndrome, widespread availability of otc artificial tears, growth in aging population, higher use of contact lenses, established retail pharmacy networks.

What Is The OTC Dry Eye Drops Market Growth Forecast?

The otc dry eye drops market size is expected to see strong growth in the next few years. It will grow to $5.33 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising screen time and digital eye strain, growing awareness of eye health, expansion of e-commerce pharmacy platforms, demand for long-lasting and advanced formulations, increasing preference for preservative-free products. Major trends in the forecast period include rising demand for preservative-free eye drops, growing adoption of otc solutions for screen-induced dry eye, expansion of premium and enhanced-ingredient formulations, increasing preference for self-medication and preventive eye care, growth of online and direct-to-consumer distribution channels.

Global OTC Dry Eye Drops Market Segmentation

1) By Brand Classification: Generics, Branded 2) By Product: Preservatives Free, With Preservatives 3) By Viscosity: High Viscosity, Low Viscosity 4) By Distribution Channel: Online Pharmacies, Drugstores And Supermarkets, Retail Pharmacies, Other Distribution Channels Subsegments: 1) By Generics: Artificial Tears (Non-Prescription), Lubricating Drops, Moisturizing Eye Drops, Rewetting Drops For Contact Lens Wearers 2) By Branded: Brand-Specific Artificial Tears (Blink, Systane, Refresh), Prescription-To-Otc Switch Brands, Premium Lubricating Drops (With Added Ingredients Like Hyaluronic Acid, Vitamins)

What Is The Driver Of The OTC Dry Eye Drops Market?

The increasing screen exposure is expected to propel the growth of the OTC dry eye drops market going forward. Screen exposure refers to the prolonged use of digital devices such as smartphones, computers, tablets, and televisions, which emit blue light and require sustained visual focus, often leading to digital eye strain. The rise in screen exposure is driven by expanding digital lifestyles, remote working trends, increased dependence on online communication, and widespread accessibility of connected devices. OTC dry eye drops support ocular comfort by offering quick and convenient relief from dryness, irritation, and fatigue associated with extended screen time. For instance, in March 2025, according to the Mastermind Behavior Services, a US-based company, in 2024, the global average daily screen time is roughly 6 hours and 40 minutes, whereas adults in the U.S. spend an average of 7 hours and 3 minutes per day on screens. Therefore, the increasing screen exposure is driving the growth of the OTC dry eye drops industry.

Key Players In The Global OTC Dry Eye Drops Market

Major companies operating in the otc dry eye drops market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis International AG, Allergan plc, Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Ltd., Sentiss Pharma Private Limited, VISUfarma B.V., Ursapharm Arzneimittel GmbH, Thea Pharmaceuticals Inc., Horus Pharma, Novaliq GmbH, Medicom Healthcare Ltd., Similasan AG, Altaire Pharmaceutical Inc.

What Are Latest Mergers And Acquisitions In The OTC Dry Eye Drops Market?

In July 2023, Bausch + Lomb Corporation, a US-based healthcare company, acquired Blink eye and contact lens drops from Johnson & Johnson Vision for an undisclosed amount. With this acquisition, Bausch + Lomb aims to expand its over-the-counter (OTC) eye care portfolio and strengthen its presence in the fast-growing dry eye and ocular hydration market. Johnson & Johnson is a US-based healthcare company focused on innovative medicine and medtech.

Regional Insights

North America was the largest region in the OTC dry eye drops market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the OTC Dry Eye Drops Market?

The OTC dry eye drops market consists of sales of eye drops with hyaluronic acid, lubricating eye gels, preservative-free drops, and eye drops with lipid-based formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the OTC Dry Eye Drops Market Report 2026?

The otc dry eye drops market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the otc dry eye drops industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

OTC Dry Eye Drops Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$4.07 billion
Revenue Forecast In 2035$5.33 billion
Growth RateCAGR of 8.1% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredBrand Classification, Product, Viscosity, Distribution Channel
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledPfizer Inc., Johnson & Johnson Services Inc., Novartis International AG, Allergan plc, Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Ltd., Sentiss Pharma Private Limited, VISUfarma B.V., Ursapharm Arzneimittel GmbH, Thea Pharmaceuticals Inc., Horus Pharma, Novaliq GmbH, Medicom Healthcare Ltd., Similasan AG, Altaire Pharmaceutical Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The OTC Dry Eye Drops market was valued at $3.77 billion in 2025, increased to $4.07 billion in 2026, and is projected to reach $5.33 billion by 2030.
request a sample here
The global OTC Dry Eye Drops market is expected to grow at a CAGR of 7.0% from 2026 to 2035 to reach $5.33 billion by 2035.
request a sample here
Some Key Players in the OTC Dry Eye Drops market Include, Pfizer Inc., Johnson & Johnson Services Inc., Novartis International AG, Allergan plc, Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Ltd., Sentiss Pharma Private Limited, VISUfarma B.V., Ursapharm Arzneimittel GmbH, Thea Pharmaceuticals Inc., Horus Pharma, Novaliq GmbH, Medicom Healthcare Ltd., Similasan AG, Altaire Pharmaceutical Inc. .
request a sample here
Major trend in this market includes: Shift Toward Preservative-Free Technologies Enhances Safety and Long-Term Tolerability in OTC Dry Eye Drops . For further insights on this market.
request a sample here
North America was the largest region in the OTC dry eye drops market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the otc dry eye drops market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us